Valuation : BOIRON

Market Cap 446M 520M 418M 383M 721M 49.65B 723M 4.95B 1.93B 25.02B 1.95B 1.91B 82.81B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 398M 464M 373M 342M 643M 44.32B 645M 4.42B 1.73B 22.34B 1.74B 1.7B 73.93B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 week-1.14%
Current month-3.69%
1 month-3.69%
3 months-5.43%
6 months-3.33%
Current year-12.42%
1 week 26.1
Extreme 26.1
26.4
1 month 26.1
Extreme 26.1
27.5
3 years 20.5
Extreme 20.5
55.9
5 years 20.5
Extreme 20.5
55.9
10 years 20.5
Extreme 20.5
91.9
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2025
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 65 01/07/2011
Director/Board Member 54 10/03/2010
Director/Board Member 51 23/05/2013
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.51%+23.99%-50.75% 520M
+1.01%+1.01%-13.78%-5.57% 13.27B
+1.98%+0.33%-35.14%-57.05% 4.97B
+1.85%-5.05%-6.75%-2.34% 4.65B
+1.58%-4.23%-1.29%-28.74% 4.04B
+1.01%+0.61%-21.17%+5.44% 3.59B
+2.21%+3.87%-6.13%-3.71% 3.46B
-0.47%-4.16%-13.69%+11.83% 3.29B
+0.86%-3.04%-19.63%-15.55% 2.43B
+1.82%-1.23%-31.46%-11.34% 1.71B
Average +1.32%-1.10%-12.51%-15.78% 4.6B
Weighted average by Cap. +1.28%-0.82%-14.92%-12.45%

Financials

2024 2025
Net sales 488M 568M 456M 418M 787M 54.25B 790M 5.41B 2.11B 27.34B 2.13B 2.09B 90.48B 501M 584M 469M 430M 809M 55.75B 812M 5.56B 2.17B 28.1B 2.19B 2.14B 93B
Net income 11.34M 13.21M 10.61M 9.72M 18.31M 1.26B 18.36M 126M 49.13M 636M 49.58M 48.51M 2.1B 32.64M 38.03M 30.56M 27.98M 52.72M 3.63B 52.87M 362M 141M 1.83B 143M 140M 6.06B
Net Debt -49.74M -57.94M -46.57M -42.64M -80.32M -5.53B -80.55M -551M -216M -2.79B -218M -213M -9.23B -47.86M -55.75M -44.8M -41.03M -77.28M -5.32B -77.5M -531M -207M -2.68B -209M -205M -8.88B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
-
Date Price Change
28/08/26 EUR 26.10 0.00%
27/08/26 EUR 26.10 0.00%
26/08/26 EUR 26.10 -0.38%
25/08/26 EUR 26.20 -0.76%
24/08/26 EUR 26.40 0.00%

Annual profits - Rate of surprise